Chronic Total Occlusion Crossing With the Wildcat Catheter

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

June 30, 2011

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Chronic TOtAl OcclusioN CrossiNg with thE WildCat CatheTer

A Non-Randomized Study of the Avinger Wildcat™ used to Cross Chronic Total Occlusions in the Superficial Femoral and Popliteal Arteries

Trial Locations (15)

30308

Emory University Hospital, Atlanta

32501

Coastal Vascular, Pensacola

35235

Birmingham Heart Clinic, Birmingham

43606

Jobst Vascular Center, Toledo

48201

Detroit Medical Center, Detroit

48236

St. John Hospital and Medical Center, Detroit

48858

Central Michigan Community Hospital, Mount Pleasant

63110

St. Louis University, St Louis

78756

Austin Heart, Austin

79902

Cardiology Care Consultants, El Paso

El Paso Cardiology Associates, El Paso

85006

Phoenix Heart Center, Phoenix

85206

Arizona Regional / Adventis, Mesa

92123

Sharp Memorial, San Diego

95619

Sutter Memorial, Sacramento

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Avinger, Inc.

INDUSTRY

NCT01174784 - Chronic Total Occlusion Crossing With the Wildcat Catheter | Biotech Hunter | Biotech Hunter